Selecting the right connectivity for the next generation of medical devices

Sponsored by: Flex

Focused on:

  • Connectivity
  • Next Generation Medical Devices

Date: 12 February


Time: 3PM London/10AM New York

One size does not fit all

The value of the IoT market specific to medical technology is estimated to be over $41 billion USD in 2017 and is expected to grow to $158 billion by 2022. Of that total, the connected medical devices segment used in drug delivery, patient monitoring, diagnosis or treatment of patients makes up roughly 1/3 of that market and is estimated to grow by $37 billion USD in the next 5 years (MarketsandMarkets). Concomitant with this evolution in devices, connectivity technology is evolving at record pace in its own right. Matching the optimal connectivity technology to the connectivity needs, useful life, and desired cost profile of the device can make the difference between a successful product with strong adoption and something less than that.

Since 2013 FDA recognised the need for an organized, risk-based approach with its “Radio Frequency Wireless Technology in Medical Devices” guidance to “identify and appropriately address specific considerations related to the incorporation and integration of radio frequency (RF) wireless technology in medical devices.”
The selection of the right connectivity technology for a new medical device is indeed a critical activity that goes beyond the regulatory assessment and has deep ramifications at all design levels.

In this webinar, we’ll start from the market and technology drivers behind the rush to ubiquitous connectivity and we’ll discuss a wide range of needs assessment and trade-offs ranging from usability to power consumption to provide a clear guidance on how to move forward in this space with examples of connected products on the market and analysing the key selection criteria.

Engage with experts in connectivity technology and applications in drug delivery and medical devices to learn key considerations for successful connected device development.

Presented by

Tommaso Borghi, PhD,

Flex Design Program Manager

In the past 10 years within Flex, Tommaso Borghi led R&D teams through the development of connected devices for top medical devices and pharmaceutical companies working in close collaboration with marketing departments, top design firms and production sites around the world. He created partnerships with Italian universities and led programs with European research centers to bring cutting-edge technologies into the market. He holds several patents and published research papers in international peer-reviewed journals. Tommaso holds a PhD in Electrical Engineering from Politecnico di Milano and worked as Visiting Scientist at the Massachusetts Institute of Technology on the development of Brain Machine Interfaces.

Lior Shtram,

Senior Director Design & Engineering

Lior Shtram is a Senior Director of Technology Management at Flex Health Solutions, a Flextronics company that provides design and manufacturing services for medical devices. Lior has graduated from the Technion institute of Technology Israel. Lior has over 20 years of experience in the electronics industry, covering a wide variety of markets ranging from semiconductors and communication systems to medical devices. Lior has more than 10 years of experience in the medical device industry, helping to bring to market multiple medical devices such as diagnostic meters and drug delivery systems.

Key Learning Objectives

  • Learn how the need for patient data is driving the push to ubiquitous connectivity
  • Understand FDA guidance on radio frequency wireless technology in medical devices
  • Learn the drivers for selecting the right technologies
  • Understand how to choose the right components: modules vs. discrete, off-the-shelf vs. custom


  • C-Suite levels
  • Heads of Research and Development
  • Operations Managers
  • Operations Directors
  • Operations VPs
  • . Purchasing Directors
  • Purchasing VPs
  • Quality Directors and Quality VPs